Emcure Pharmaceuticals Limited (NSE:EMCURE)

Emcure Pharmaceuticals Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	May 11, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Market Capitalization	311,496	302,490	203,202	-	-	-
Market Cap Growth	49.61%	48.86%	-	-	-	-
Enterprise Value	325,499	315,376	214,615	-	-	-
Last Close Price	1643.00	1595.50	1070.19	-	-	-
PE Ratio	33.69	32.72	29.82	-	-	-
Forward PE	27.22	27.50	24.17	-	-	-
PS Ratio	3.38	3.28	2.57	-	-	-
PB Ratio	6.26	6.08	4.38	-	-	-
P/TBV Ratio	8.09	7.86	5.81	-	-	-
P/FCF Ratio	53.43	51.89	32.26	-	-	-
P/OCF Ratio	33.01	32.06	23.86	-	-	-
PEG Ratio	1.22	1.02	0.93	-	-	-
EV/Sales Ratio	3.53	3.42	2.72	-	-	-
EV/EBITDA Ratio	18.07	17.51	15.20	-	-	-
EV/EBIT Ratio	23.48	22.75	19.79	-	-	-
EV/FCF Ratio	55.83	54.10	34.07	-	-	-
Debt / Equity Ratio	0.31	0.31	0.22	0.75	0.88	1.05
Debt / EBITDA Ratio	0.84	0.84	0.70	1.91	1.99	1.68
Debt / FCF Ratio	2.61	2.61	1.62	2.84	6.55	5.69
Net Debt / Equity Ratio	0.28	0.28	0.17	0.60	0.71	0.97
Net Debt / EBITDA Ratio	0.76	0.76	0.56	1.58	1.65	1.59
Net Debt / FCF Ratio	2.36	2.36	1.26	2.27	5.30	5.27
Asset Turnover	1.03	1.03	0.99	0.92	0.94	0.91
Inventory Turnover	1.67	1.67	1.80	1.66	1.54	1.47
Quick Ratio	0.71	0.71	0.86	0.75	0.72	0.51
Current Ratio	1.43	1.43	1.71	1.33	1.27	1.16
Return on Equity (ROE)	19.57%	19.57%	18.23%	18.28%	23.59%	31.35%
Return on Assets (ROA)	9.71%	9.71%	8.45%	7.92%	9.04%	10.54%
Return on Invested Capital (ROIC)	16.38%	17.21%	15.16%	13.97%	15.92%	18.40%
Return on Capital Employed (ROCE)	24.30%	24.30%	19.50%	20.00%	25.20%	35.00%
Earnings Yield	2.97%	3.06%	3.35%	-	-	-
FCF Yield	1.87%	1.93%	3.10%	-	-	-
Dividend Yield	0.18%	-	0.28%	-	-	-
Payout Ratio	6.15%	6.15%	-	10.89%	6.80%	8.19%
Buyback Yield / Dilution	-1.33%	-1.33%	-3.41%	-0.01%	-	-
Total Shareholder Return	-1.15%	-1.33%	-3.13%	-0.01%	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.